Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19
G. Canderan, L. Muehling, A. Kadl, S. Ladd, C. Bonham, C. Cross, S. Lima, X. Yin, J. Sturek, J. Wilson, B. Keshavarz, N. Bryant, D. Murphy, I. S. Cheon, C. McNamara, , J. Woodfolk
The paper identifies distinct type 1 immune networks associated with varying severities of restrictive lung disease following COVID-19.
bioRxiv · Apr 3, 2024Immunology